Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The treatment showed high response rates and was well-tolerated, potentially extending patient survival.

Risankizumab may help manage symptoms of dissecting cellulitis of the scalp.

Infliximab improved skin and bowel symptoms in Crohn's disease but caused side effects and the disease returned after stopping treatment.

Deucravacitinib may help treat various immune diseases beyond psoriasis, but more research is needed.

Silicate-based therapy may help treat inflammatory heart disease by reducing immune inflammation.

Mice with human fetal thymic tissue and stem cells developed symptoms similar to chronic graft-versus-host disease.

Foxp3 is crucial for regulatory T cell function, and targeting these cells may help treat immune disorders.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.

The folate-cyclodextrin conjugate targets cancer cells more precisely, potentially reducing chemotherapy side effects.

The treatment was not recommended due to limited effectiveness and significant side effects.

LDL apheresis lowers inflammation and cardiovascular risk by reducing CRP levels long-term.

Low-dose DMSO may help treat castration-resistant prostate cancer by reducing key cancer cell receptors.

Allergens might contribute to CCCA, so avoiding them could help manage the condition.

Clonally expanded CD8+ T cells cause alopecia areata.

Non-coding RNA boosts retinoic acid production and signaling, aiding regeneration.

Early diagnosis and multidisciplinary care are crucial for managing CNOT3 syndrome.

A patient with multiple sclerosis developed skin reactions after Daclizumab treatment, requiring more data on the drug's effects.

The new aptamer TAGX-0003 shows promise as an effective treatment for hair loss disorder alopecia areata.

Targeting androgen receptors shows promise for treating triple-negative breast cancer, but more research is needed.

CTP-543 is generally safe for treating alopecia areata.

The microenvironment affects the behavior and survival of melanocytes with the GNAQ oncogene in melanoma.

Thymus transplantation successfully restored immune function in infants with FOXN1 deficiency.

Ritlecitinib effectively treats alopecia areata and is well-tolerated.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Topical patidegib gel effectively treats basal cell carcinoma in Gorlin syndrome patients without causing the side effects seen with oral treatments.

Antibody drug conjugates show promise in targeting cancer cells while reducing harm to healthy cells.

Ritlecitinib shows promise as a versatile treatment for various autoimmune and inflammatory diseases.

PRMT5 inhibitors effectively fight adenoid cystic carcinoma in salivary glands.

Researchers discovered how to control Claudin expression in cells, aiding cancer and regenerative medicine research.

CMX from Centipeda minima can significantly improve hair growth in mild to moderate balding.